quit talking about the "shorts" in every damn post of yours
quit talking about the "shorts" in every damn post of yours like they control every move on this stock. GUESS WHAT? They don't.
you seem to think that anyone that isn't long on ambs is a "SHORT GUY". anyone who doesn't own shares is SHORT. anyone who doesn't pump the stock is a SHORT, anyone who isn't bowing down to ambs and their products and management team is SHORT.
no.
you sound like an idiot.
please stop.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...
Continue Reading
A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...
Continue Reading
IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...
Continue Reading
A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...
Continue Reading
Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...
Continue Reading
Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...
Continue Reading
Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...
Continue Reading
Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...
Continue Reading
Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...
Continue Reading
A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...
Continue Reading
Top 5 Most Recently Viewed Articles
HDFC AMC Stock to Benefit from Growth Potential Recent analysis by Nomura has thrown the spotlight on HDFC Asset Management Company Ltd (HDFCAMC:IN), revealing an optimistic outlook for the stock. They initiated coverage with a Buy rating and set a price target of INR 5,000, emphasizing the company's strong ability to leverage opportunities in India's growing asset...
Continue Reading
Exciting Developments in ALS Treatment Oslo University Hospital is taking a significant step forward in the treatment of Amyotrophic Lateral Sclerosis (ALS) with the commencement of a multicenter randomized phase 2 trial of ILB®. This innovative study aims to compare the efficacy of ILB®, a promising new treatment, against Riluzole, the current standard of care for ALS...
Continue Reading
U.S. Conference of Mayors Addresses Current Urban Issues The U.S. Conference of Mayors is focused on the pressing challenges that urban leadership faces in today's environment. In a recent statement, President Andrew Ginther, who is also the Mayor of Columbus, emphasized the importance of local governance in maintaining public safety. "The streets of American cities are...
Continue Reading
LATG Stock Surges to New All-Time High In a remarkable display of market confidence, LATG stock has experienced a surge, reaching an impressive milestone at $11.84. This achievement signifies the company's strong performance over the past year. Investors have responded positively, reflecting their optimism in LATG's strategic direction and growth potential, which is...
Continue Reading
Dr. Kingsley R. Chin's Legal Resolution After enduring a rigorous investigation by the Department of Justice (DOJ) for seven years, Dr. Kingsley R. Chin has emerged with all original Anti-Kickback charges dismissed. While he consented to a plea settlement regarding a singular issue related to Open Payments reporting, Dr. Chin is now primed to continue advancing innovative...
Continue Reading